These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38386150)

  • 1. Late/delayed gadolinium enhancement in MRI after intravenous administration of extracellular gadolinium-based contrast agents: is it worth waiting?
    Parillo M; Mallio CA; Dekkers IA; Rovira À; van der Molen AJ; Quattrocchi CC;
    MAGMA; 2024 Apr; 37(2):151-168. PubMed ID: 38386150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac magnetic resonance imaging and the myocardium : Differentiation between vital and nonvital tissue].
    Alachkar MN; Mischke T; Mahnkopf C
    Herzschrittmacherther Elektrophysiol; 2022 Sep; 33(3):272-277. PubMed ID: 35781833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic multi-contrast late gadolinium enhancement imaging using post-contrast magnetic resonance fingerprinting.
    Rashid I; Al-Kindi S; Rajagopalan V; Walker J; Rajagopalan S; Seiberlich N; Hamilton JI
    NMR Biomed; 2024 Jan; 37(1):e5043. PubMed ID: 37740596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart.
    Schelbert EB; Hsu LY; Anderson SA; Mohanty BD; Karim SM; Kellman P; Aletras AH; Arai AE
    Circ Cardiovasc Imaging; 2010 Nov; 3(6):743-52. PubMed ID: 20847191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy - a prospective clinical cardiovascular magnetic resonance trial.
    Muehlberg F; Arnhold K; Fritschi S; Funk S; Prothmann M; Kermer J; Zange L; von Knobelsdorff-Brenkenhoff F; Schulz-Menger J
    J Cardiovasc Magn Reson; 2018 Feb; 20(1):13. PubMed ID: 29458430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic late gadolinium enhancement cardiac magnetic resonance for diagnosing myocardial scar.
    Abdula G; Nickander J; Sörensson P; Lundin M; Kellman P; Sigfridsson A; Ugander M
    Scand Cardiovasc J; 2018 Jun; 52(3):127-132. PubMed ID: 29544374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of late gadolinium enhancement in pediatric cardiac MRI.
    Etesami M; Gilkeson RC; Rajiah P
    Pediatr Radiol; 2016 Jul; 46(8):1096-113. PubMed ID: 26718199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-Heart High-Resolution Late Gadolinium Enhancement: Techniques and Clinical Applications.
    Toupin S; Pezel T; Bustin A; Cochet H
    J Magn Reson Imaging; 2022 Apr; 55(4):967-987. PubMed ID: 34155715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of myocardial fibrosis in an age-related rat model by ex vivo late gadolinium enhancement magnetic resonance imaging with histopathological correlation.
    Beliveau P; Cheriet F; Anderson SA; Taylor JL; Arai AE; Hsu LY
    Comput Biol Med; 2015 Oct; 65():103-13. PubMed ID: 26313531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy.
    Raafs AG; Verdonschot JAJ; Henkens MTHM; Adriaans BP; Wang P; Derks K; Abdul Hamid MA; Knackstedt C; van Empel VPM; Díez J; Brunner-La Rocca HP; Brunner HG; González A; Bekkers SCAM; Heymans SRB; Hazebroek MR
    Eur J Heart Fail; 2021 Jun; 23(6):933-944. PubMed ID: 33928704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure.
    Wong TC; Piehler KM; Zareba KM; Lin K; Phrampus A; Patel A; Moon JC; Ugander M; Valeti U; Holtz JE; Fu B; Chang CC; Mathier M; Kellman P; Butler J; Gheorghiade M; Schelbert EB
    J Am Heart Assoc; 2013 Nov; 2(6):e000416. PubMed ID: 24249712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of factors affecting late gadolinium enhancement kinetics in MRI of cardiac amyloid.
    Axel L
    J Cardiovasc Magn Reson; 2023 Aug; 25(1):46. PubMed ID: 37563646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and evaluation of myocardial fibrosis in Eisenmenger syndrome using cardiovascular magnetic resonance late gadolinium enhancement and T1 mapping.
    Gong C; Guo J; Wan K; Wang L; Chen X; Guo J; He J; Yin L; Wen B; Pu S; Chen C; Chen Y
    J Cardiovasc Magn Reson; 2022 Nov; 24(1):60. PubMed ID: 36404313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late gadolinium enhancement on cardiac magnetic resonance predicts coronary vasomotor abnormality and myocardial lactate production in patients with chronic heart failure.
    Uemura T; Yamamuro M; Kaikita K; Takashio S; Utsunomiya D; Hirakawa K; Nakayama M; Sakamoto K; Yamamoto E; Tsujita K; Kojima S; Hokimoto S; Yamashita Y; Ogawa H
    Heart Vessels; 2016 Dec; 31(12):1969-1979. PubMed ID: 26892530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D late gadolinium enhanced cardiovascular MR with CENTRA-PLUS profile/view ordering: Feasibility of right ventricular myocardial damage assessment using a swine animal model.
    Kawaji K; Tanaka A; Patel MB; Wang H; Maffessanti F; Ota T; Patel AR
    Magn Reson Imaging; 2017 Jun; 39():7-14. PubMed ID: 28131907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
    Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
    Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis].
    Cui Q; Yu J; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast - in cardiac magnetic resonance imaging.
    Patel N; Kolakalapudi P; Arora G
    Echocardiography; 2018 Mar; 35(3):401-409. PubMed ID: 29474744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved myocardial scar visualization with fast free-breathing motion-compensated black-blood T
    Sridi S; Nuñez-Garcia M; Sermesant M; Maillot A; Hamrani DE; Magat J; Naulin J; Laurent F; Montaudon M; Jaïs P; Stuber M; Cochet H; Bustin A
    Diagn Interv Imaging; 2022 Dec; 103(12):607-617. PubMed ID: 35961843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.